天天干天天操天天爽,国产综合免费,91久久国产,天天综合国产,天天干视频网,国产91视频观看,国产综合在线观看视频

首頁(yè) /科研細胞 /人源細胞系 /血液 /K562(人慢性粒細胞白血病細胞)

K562(人慢性粒細胞白血病細胞)

CBP60529

產(chǎn)品描述
產(chǎn)品數據庫
I. General information 
Synonyms: K562
Background: The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises.
Species: Homo sapiens, human
Tissue: bone marrow
Disease: leukemia
Gender: female.53 yearss
Morphology: lymphoblast
Growth Mode: suspension
DNA Profile: Amelogenin: X
CSF1PO: 9,10
D13S317: 8
D16S539: 11,12
D5S818: 11,12
D7S820: 9,11
THO1: 9.3
TPOX: 8,9
vWA: 16
Our Cell Line Authentication Service
Culture Medium:

RPMI-1640+10%FBS

K562完全培養基,# CBP60529M
We strongly suggest to purchase the complete medium from us.

Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: CD7 (25%)
Tumor Formation: Yes, in nude mice.  Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 107 cells 
Comments: The cell population has been characterized as highly undifferentiated and of the granulocytic series. Studies conducted by Anderson, et al., on the surface membrane properties led to the conclusion that the K-562 was a human erythroleukemia line.
K-562 blasts are multipotential, hematopoietic malignant cells that spontaneously differentiate into recognizable progenitors of the erythrocytic, granulocytic and monocytic series.The effect of inducers on sublines derived from the original K-562 cell line have been reviewed by Koeffler and Golde.Karyological studies on various K-562 sublines have been classified into three groups (A,B,C) by Dimery, et al.The strain obtained by the ATCC most closely resembles the B population. Occurrence of the Philadelphia chromosome, however, was of much lower frequency; none detected in 15 metaphases examined.The line is EBNA negative.
For more information, please contact us (4008-750-250).

客服

微信

掃一掃,添加二維碼

電話(huà)

留言

藥靶模型聯(lián)系方式: 華東銷(xiāo)售經(jīng)理(上海):18240630236 華東銷(xiāo)售經(jīng)理(上海、江蘇、安徽):15715191010 華北銷(xiāo)售經(jīng)理:18628311252 華南銷(xiāo)售經(jīng)理:13823536064 華中&華西銷(xiāo)售經(jīng)理:18071545918 華中&西南銷(xiāo)售經(jīng)理:13871580511 全國銷(xiāo)售經(jīng)理:13816461235
診斷標準品聯(lián)系方式: 華東銷(xiāo)售經(jīng)理:15000320447 華北銷(xiāo)售經(jīng)理:18628311252 華南銷(xiāo)售經(jīng)理:13823536064 華中&華西銷(xiāo)售經(jīng)理:18071545918 華中&西南銷(xiāo)售經(jīng)理:13871580511 全國銷(xiāo)售經(jīng)理:13816461235

掃二維碼

立即提交
武川县| 乐陵市| 武功县| 洛隆县| 桐梓县| 龙南县| 达日县| 循化| 长乐市| 包头市| 彭水| 江孜县| 永仁县| 乐昌市| 类乌齐县| 秀山| 惠安县| 锡林浩特市| 博兴县| 楚雄市| 新郑市| 呈贡县| 泗洪县| 高淳县| 濮阳市| 梅州市| 深圳市| 揭东县| 贵阳市| 云安县| 出国| 岱山县| 广州市| 咸阳市| 新昌县| 阿巴嘎旗| 四子王旗| 湘乡市| 蓬溪县| 荃湾区| 建湖县|